CX NEWS
EVAR funding threatened, while strategy for safe, cost-effective repair is “just around the corner”
The durability of endovascular aneurysm repair (EVAR) is in the limelight as the UK vascular community awaits the final aortic aneurysm guidelines from the National Institute for Health and Care Excellence (NICE), set to [...]
Vascular recruitment a “universal problem”: The global perspective
Sophie Renton Across the globe, vascular recruitment is struggling. This was the reason why delegates convened in the Upper Auditorium yesterday afternoon for a CX Highlight Session dedicated to the topic, where [...]
Don’t miss: The influence of hyperglycaemia on spinal cord injury
Jade Hiramoto (San Francisco, USA) tells CX Live about why she believes “everyone should consider normalising glucose levels after long, complex endovascular aortic procedures—and maybe even after open thoracoabdominal aortic procedures.” Hiramoto is presenting [...]
CX 2019: Why a signed consent form “is not consent”
Jonathan Beard, (Sheffield, UK), discusses the current medicolegal issues in the field and explains how vascular surgeons can become “the fall-guy for the inadequacies of other clinicians”. Beard touches on how the threshold for [...]
News from CX 2019: Evidence supports safety of paclitaxel-coated devices
At the Charing Cross International Symposium, Gary Ansel (Columbus, Ohio) moderates a global panel that includes Thomas Albrecht (Berlin, Germany), Peter Schneider (San Francisco, USA) and Eric Secemsky (Boston, USA). The panel outlines the [...]
Podium 1st: The impact of polymer sealing on neck-related adverse events: Five-year results from ENCORE
Recorded presentation from CX Symposium 2019 Hence Verhagen, Rotterdam, Netherlands